newsfilter
← Latest News
PR Newswire·

Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

TEL AVIV, Israel, Nov. 26, 2025 /PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage...